Cannabis as Medicine

Legal on paper does not mean safe on the job. That blunt message runs through a major legal reference for employers. The drug free workplace facts it sets out deserve a far wider audience. It all comes from Drug Testing Law, Technology and Practice, February 2026 update, written by David Evans and published by Thomson

A driver eats a cannabis gummy, waits a while, gets behind the wheel and returns a low THC reading. Surely that settles it? A new randomised trial says it does not. Cannabis edibles and driving do not follow the tidy rule that a small number in the blood means a clear head.That rule matters because

The cannabis cure myth survives on two words. Potential. Continuing. Both keep reappearing through the scientific literature. Three studies anchor this review: a 2009 pharmacology survey, a 2017 phytochemistry review, and a 2023 chemical analysis. Together, they span fourteen years of dedicated research into a single plant. Even so, none of the three claims a

PMID: 41801216 . DOI: 10.1001/jamainternmed.2025.8215 Abstract Importance: Cannabis use is common among those with mental health conditions, and many people report using cannabis to manage mental health symptoms. It is important for clinicians to understand the lack of clear benefits of cannabis for mental health conditions and the potential for substantial adverse effects. Observations: Overall, the potential benefits of

For many people, cannabis now sits in the same mental basket as a glass of wine or a herbal sleep aid: familiar, legal in some places, and often marketed as a “natural” way to unwind. But a major new brain‑imaging study of more than 1,000 young adults suggests that heavy cannabis use may quietly weaken

A habit that millions of people consider harmless could be quietly raising the odds of a heart attack. A major new review, published in The American Journal of Medicine, has pulled together years of research on cannabis use and heart attack risk, and the picture it paints is far from reassuring, especially for younger adults

Received April 16, 2026; Published online April 22, 2026 DOI: 10.1016/j.lungcan.2026.109421 External Link   Highlights Individuals with cannabis use disorder had an increased risk of any lung and/or bronchus cancer in this cohort study. Increased risk for small cell carcinoma, squamous cell carcinoma, and adenocarcinoma was observed. Further studies are required to explore the strength of this

 Background. Cannabidiol (CBD) now dominates consumer health markets worldwide. Manufacturers market it predominantly on the basis of perceived safety. However, CBD carcinogenicity FDA evidence, generated during the pharmaceutical approval process for purified CBD (Epidiolex, GW Research Ltd, NDA 210365), raises substantive concerns that regulators have not communicated to the public, prescribers, or policymakers. Evidence reviewed. This